Mirogabalin as a Novel Gabapentinoid for the Treatment of Chronic Pain Conditions: An Analysis of Current Evidence

Neuropathic pain is a challenge for physicians to treat and often requires a multimodal approach with both pharmacologic and lifestyle interventions. Mirogabalin, a potent, selective ligand of the α2δ-1 and α2δ-2 subunits of voltage-gated calcium channels (VGCCs), provides analgesia by inhibiting ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Eric Y., Beutler, Sascha S., Kaye, Alan D., Edinoff, Amber N., Khademi, Seyed-Hossein, Stoltz, Andrea E., Rueb, Nicole R., Cornett, Elyse M., Suh, Winston J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Briefland 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909537/
https://www.ncbi.nlm.nih.gov/pubmed/35291398
http://dx.doi.org/10.5812/aapm.121402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909537/
https://www.ncbi.nlm.nih.gov/pubmed/35291398
http://dx.doi.org/10.5812/aapm.121402

Ejemplares similares